United Drug ‘still open to resuming its Iseq listing’

United Drug has said that it remains open to the option of resuming a listing on the Irish Stock Exchange.

The Dublin-headquartered healthcare services group — which derives 70% of its earnings from outside of Ireland — delisted from the Iseq last October, in favour of a full share listing in London.

Addressing shareholders at the group’s agm in Dublin yesterday, chairman Peter Gray said that the option of taking a dual listing, here, “will be kept under review”.